Total white matter hyperintensity volume in bipolar disorder patients and their healthy relatives

Bipolar Disorders - Tập 14 Số 8 - Trang 888-893 - 2012
Sarah K. Tighe1, Sarah Reading1,2,3, Paul Rivkin1, Brian Caffo4, Barbara Schweizer1, Godfrey D. Pearlson5,6, James B. Potash7, J. Raymond DePaulo1, Susan Spear Bassett1
1Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD
2Department of Psychiatry and Neuroscience, University of South Florida, Tampa, FL
3Mental Health and Behavioral Science Service, The James A. Haley Veterans' Hospital, Tampa, FL
4Department of Biostatistics, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD
5Departments of Psychiatry and Neurobiology, Yale University, New Haven, CT
6Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, CT
7Department of Psychiatry, The University of Iowa, Iowa City, IA, USA

Tóm tắt

Tighe SK, Reading SA, Rivkin P, Caffo B, Schweizer B, Pearlson G, Potash JB, DePaulo J Raymond, Bassett SS. 
Total white matter hyperintensity volume in bipolar disorder patients and their healthy relatives. 
Bipolar Disord 2012: 14: 888–893. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd.Objectives: White matter hyperintensities (WMH) are more common in subjects with bipolar disorder (BP) than in healthy subjects (HS). Few studies have examined the effect of the diagnostic type of bipolar illness on WMH burden, and none have approached this question through a direct measurement of the volume of affected white matter in relationship to familiality. In this pilot study, we utilized a volumetric measurement of WMH to investigate the relationship between the total volume of WMH and the familiality and type of BP.Methods: Forty‐five individuals with bipolar I disorder (BP‐I) with psychotic features, BP‐I without psychotic features, or bipolar II disorder (BP‐II), seven of their unaffected relatives, and 32 HS were recruited for participation. T‐2 weighted magnetic resonance imaging scans were obtained on all subjects, and the total volume of all WMH for each subject was measured in cubic centimeters. The significance of difference between groups was tested using ANOVA with post‐hoc adjustment for multiple comparisons. Further, we used logistic regression to test for trends between symptom load and total WMH volume.Results: The mean total volume of WMH in BP‐I patients with psychotic features was significantly higher (p < 0.05) than that of HS. Further, we observed a positive linear trend by familiality and type of affectedness when comparing mean total WMH volume of HS, unaffected family members, subjects with BP‐II, and BP‐I with and without a history of psychosis (p < 0.05).Conclusions: Based on a quantitative technique, WMH burden appears to be associated with familiality and type of BP. The significance of these findings remains to be fully elucidated.

Từ khóa


Tài liệu tham khảo

10.1111/j.1440-1819.2004.01294.x

10.1176/ajp.152.8.1139

10.1176/ajp.151.5.687

10.1176/jnp.3.1.18

10.1111/j.1600-0447.2009.01416.x

10.1016/S0006-3223(98)00341-2

10.1001/archpsyc.1990.01810230070011

10.1080/09540260902962198

10.1001/archpsyc.65.9.1017

10.1001/archpsyc.1990.01810130057008

10.1192/bjp.178.2.172

10.1111/j.1399-5618.2010.00867.x

10.1111/j.1399-5618.2008.00626.x

10.1017/S1092852900029242

10.1007/s00406-007-0755-x

10.1176/ajp.155.11.1605

10.1016/j.arcmed.2005.04.009

10.1016/j.jpsychires.2010.04.019

10.1159/000007921

10.2214/ajr.149.2.351

10.1212/WNL.43.9.1683

10.1016/j.jad.2004.10.010

10.1136/jnnp.70.1.9

10.1017/S1355617700611062

10.1001/archpsyc.1978.01770310043002

10.1001/archpsyc.1994.03950110009002

10.1001/archpsyc.1990.01810180089012

10.1016/j.biopsych.2004.12.009

10.1002/1099-1166(200012)15:12<1085::AID-GPS250>3.0.CO;2-X

10.1016/S0165-0270(97)00049-6

10.1001/archpsyc.1990.01810130049007

10.1002/gps.930080203

Brant‐Zawaski M, 1985, MR Imaging of the aging brain: patchy white‐matter lesions and dementia, Am J Neuroradiol, 6, 675

10.1016/0165-1781(87)90020-5

10.1016/0006-3223(93)90140-9

10.1093/schbul/sbs053

10.1080/09540260701486233

10.1016/j.jpsychires.2007.05.003

10.1016/j.bbadis.2011.08.007

10.1034/j.1399-5618.2003.01208.x

10.1001/archgenpsychiatry.2011.60

10.1111/j.1399-5618.2008.00621.x

10.1161/STROKEAHA.107.508630